Invention Grant
- Patent Title: Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors
-
Application No.: US17349468Application Date: 2021-06-16
-
Publication No.: US11718595B2Publication Date: 2023-08-08
- Inventor: Paul S. Shapiro , Alexander D. Mackerell, Jr. , Jeffrey D. Hasday , Steven Fletcher
- Applicant: University of Maryland, Baltimore
- Applicant Address: US MD Baltimore
- Assignee: University of Maryland, Baltimore
- Current Assignee: University of Maryland, Baltimore
- Current Assignee Address: US MD Baltimore
- Main IPC: C07D295/03
- IPC: C07D295/03
Abstract:
Compounds that inhibit p38α MAPK protein, and methods of using the same, are provided for treating or preventing diseases such as cancer or inflammatory diseases.
Public/Granted literature
- US20210317097A1 NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS Public/Granted day:2021-10-14
Information query
